|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Department of Medicine, Division of Rheumatology, University of California San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA 94121;
Department of Medicine, University of California San Francisco Diabetes Center, University of California San Francisco, San Francisco, CA 94121; and
Xcyte, Seattle, WA 98104
An increasing number of studies indicate that a subset of CD4+ T cells with regulatory capacity (regulatory T cells; Tregs) can function to control organ-specific autoimmune disease. To determine whether abnormalities of thymic-derived Tregs play a role in systemic lupus erythematosus, we evaluated Treg prevalence and function in (New Zealand Black x New Zealand White)F1 (B/W) lupus-prone mice. To explore the potential of Tregs to suppress disease, we evaluated the effect of adoptive transfer of purified, ex vivo expanded thymic-derived Tregs on the progression of renal disease. We found that although the prevalence of Tregs is reduced in regional lymph nodes and spleen of prediseased B/W mice compared with age-matched non-autoimmune mice, these cells increase in number in older diseased mice. In addition, the ability of these cells to proliferate in vitro was comparable to those purified from non-autoimmune control animals. Purified CD4+CD25+CD62Lhigh B/W Tregs were expanded ex vivo 80-fold, resulting in cells with a stable suppressor phenotype. Adoptive transfer of these exogenously expanded cells reduced the rate at which mice developed renal disease; a second transfer after treated animals had developed proteinuria further slowed the progression of renal disease and significantly improved survival. These studies indicate that thymic-derived Tregs may have a significant role in the control of autoimmunity in lupus-prone B/W mice, and augmentation of these cells may constitute a novel therapeutic approach for systemic lupus erythematosus.
This article has been cited by other articles:
![]() |
N. Iikuni, E. V. Lourenco, B. H. Hahn, and A. La Cava Cutting Edge: Regulatory T Cells Directly Suppress B Cells in Systemic Lupus Erythematosus J. Immunol., August 1, 2009; 183(3): 1518 - 1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Allenbach, S. Solly, S. Gregoire, O. Dubourg, B. Salomon, G. Butler-Browne, L. Musset, S. Herson, D. Klatzmann, and O. Benveniste Role of Regulatory T Cells in a New Mouse Model of Experimental Autoimmune Myositis Am. J. Pathol., March 1, 2009; 174(3): 989 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Abe, S. Ueha, J. Suzuki, Y. Tokano, K. Matsushima, and S. Ishikawa Increased Foxp3+ CD4+ Regulatory T Cells with Intact Suppressive Activity but Altered Cellular Localization in Murine Lupus Am. J. Pathol., December 1, 2008; 173(6): 1682 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sharabi and E. Mozes The Suppression of Murine Lupus by a Tolerogenic Peptide Involves Foxp3-Expressing CD8 Cells That Are Required for the Optimal Induction and Function of Foxp3-Expressing CD4 Cells J. Immunol., September 1, 2008; 181(5): 3243 - 3251. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hao, J. Yuan, S. Xu, M. A. Munegowda, Y. Deng, J. Gordon, Z. Xing, and J. Xiang Antigen Specificity Acquisition of Adoptive CD4+ Regulatory T Cells via Acquired Peptide-MHC Class I Complexes J. Immunol., August 15, 2008; 181(4): 2428 - 2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A La Cava T-regulatory cells in systemic lupus erythematosus Lupus, May 1, 2008; 17(5): 421 - 425. [Abstract] [PDF] |
||||
![]() |
R. P. Singh, A. La Cava, and B. H. Hahn pConsensus Peptide Induces Tolerogenic CD8+ T Cells in Lupus-Prone (NZB x NZW)F1 Mice by Differentially Regulating Foxp3 and PD1 Molecules J. Immunol., February 15, 2008; 180(4): 2069 - 2080. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Cuda, S. Wan, E. S. Sobel, B. P. Croker, and L. Morel Murine Lupus Susceptibility Locus Sle1a Controls Regulatory T Cell Number and Function through Multiple Mechanisms J. Immunol., December 1, 2007; 179(11): 7439 - 7447. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |